FDA — authorised 6 August 2007
- Application: NDA022128
- Marketing authorisation holder: VIIV HLTHCARE
- Status: approved
🇺🇸 Selzentry in United States
FDA authorised Selzentry on 6 August 2007
Marketing authorisations
FDA — authorised 4 November 2016
- Application: NDA208984
- Marketing authorisation holder: VIIV HLTHCARE
- Status: approved
FDA
- Status: approved
Other Infectious Disease approved in United States
Frequently asked questions
Is Selzentry approved in United States?
Yes. FDA authorised it on 6 August 2007; FDA authorised it on 4 November 2016; FDA has authorised it.
Who is the marketing authorisation holder for Selzentry in United States?
VIIV HLTHCARE holds the US marketing authorisation.